Incorporating insulin into your daily life can take some getting used to. From packing your on-the-go bag to prepping your syringe or insulin pen, here are tips to get you started. Insulin may be one ...

Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...

A large study found many diabetic individuals who self-administer insulin are incorrectly injecting the treatment, prompting experts to create formal recommendations, Reuters reported. Of the 13,289 ...

New research offers an alternative to daily insulin shots for the 8 million people in the United States with type 2 diabetes. Eli Lilly’s once-weekly insulin injection is just as effective as daily ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. Photo by Adobe Stock/HealthDay News Weekly insulin shots can ...

Weekly insulin injections can control type 1 and type 2 diabetes just as well as daily shots, according to two new studies. Two phase 3 trials presented Tuesday at the European Association for the ...

Rapid-acting insulin (Lispro) reaches the blood within 15 minutes after injection. The insulin peaks 30 to 90 minutes later and may last as long as 5 hours. Short-acting (regular) insulin usually ...

Nature study shows a new polymer can deliver insulin through the skin, raising hopes for a painless, needle-free diabetes treatment that performs as effectively as injections ...

Fat-burning occurs best on an empty stomach, but this approach leads to adverse effects for people with insulin resistance.

For 80 years, diabetics in need of insulin have had little choice but to give themselves regular injections of the blood-sugar-regulating protein. Now, a handheld inhaler that delivers insulin orally ...

Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. A new class of insulin called efsitora alfa has been ...